CO6460777A2 - Método para el tratamiento de la fragiliad - Google Patents
Método para el tratamiento de la fragiliadInfo
- Publication number
- CO6460777A2 CO6460777A2 CO11156685A CO11156685A CO6460777A2 CO 6460777 A2 CO6460777 A2 CO 6460777A2 CO 11156685 A CO11156685 A CO 11156685A CO 11156685 A CO11156685 A CO 11156685A CO 6460777 A2 CO6460777 A2 CO 6460777A2
- Authority
- CO
- Colombia
- Prior art keywords
- vitamin
- treatment
- provides
- fragiliad
- frailty
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Revelado es un método de tratamiento o de prevención de la fragilidad en un paciente de edad avanzada, particularmente, teniendo una edad de 60 años o mayor edad. El método provee la administración parenteral acompañante de una combinación de un esteroide anabólico y un compuesto de vitamina D. Una combinación preferida comprende decanoato de nandrolona y colecalciferol (Vitamina D3). La invención, en una otra preferencia, provee una terapia reforzadora para apoyar a las personas de edad avanzada frágiles, que han experimentado una hospitalización o una cirugía, con el fin de retener la independencia y recuperar sus actividades físicas y mentales regulares.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09168522A EP2289555A1 (en) | 2009-08-24 | 2009-08-24 | Method of treating frailty |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6460777A2 true CO6460777A2 (es) | 2012-06-15 |
Family
ID=42016317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO11156685A CO6460777A2 (es) | 2009-08-24 | 2011-11-17 | Método para el tratamiento de la fragiliad |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10543217B2 (es) |
| EP (2) | EP2289555A1 (es) |
| JP (2) | JP2013502457A (es) |
| KR (1) | KR20120053987A (es) |
| CN (1) | CN102421450B (es) |
| AU (1) | AU2010287043B2 (es) |
| BR (1) | BRPI1011567B1 (es) |
| CA (1) | CA2759815C (es) |
| CL (1) | CL2011002863A1 (es) |
| CO (1) | CO6460777A2 (es) |
| DK (1) | DK2470214T3 (es) |
| ES (1) | ES2425095T3 (es) |
| IL (1) | IL216456A (es) |
| MX (1) | MX2011011905A (es) |
| MY (1) | MY162621A (es) |
| NZ (1) | NZ596057A (es) |
| PL (1) | PL2470214T3 (es) |
| PT (1) | PT2470214E (es) |
| RU (1) | RU2635541C2 (es) |
| SG (1) | SG176135A1 (es) |
| UA (1) | UA107928C2 (es) |
| WO (1) | WO2011025368A1 (es) |
| ZA (1) | ZA201108056B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101970893B1 (ko) | 2017-10-18 | 2019-04-19 | 동아대학교 산학협력단 | 노쇠 여부 스크리닝 장치 |
| CN109364034B (zh) * | 2018-11-26 | 2021-05-04 | 正大制药（青岛）有限公司 | 一种骨化三醇制剂及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4308264A (en) * | 1981-01-28 | 1981-12-29 | Abbott Laboratories | Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration |
| ATE253921T1 (de) * | 1991-05-06 | 2003-11-15 | Procter & Gamble | Kombinationen aus calzium und vitamin d |
| US5898038A (en) * | 1996-03-19 | 1999-04-27 | Board Of Regents, The University Of Texas System | Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors |
| US6031000A (en) * | 1998-06-23 | 2000-02-29 | Iowa State University Research Foundation, Inc. | Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
| US7261905B2 (en) * | 1999-04-07 | 2007-08-28 | Pure Bioscience | Disinfectant and method of making |
| US6638239B1 (en) * | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
| GB0307728D0 (en) | 2003-04-03 | 2003-05-07 | Tesla Engineering Ltd | Coil structure for magnetic resonance imaging |
| US8795693B2 (en) * | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| FR2860236B1 (fr) * | 2003-09-25 | 2006-01-06 | Theraptosis | Peptides possedant notamment une activite anti-angiogenique et leurs applications en therapeutique |
| WO2006135915A2 (en) * | 2005-06-13 | 2006-12-21 | Rigel Pharmaceuticals, Inc. | Methods and compositions for treating degenerative bone disorders |
| CA2882048C (en) * | 2006-02-03 | 2020-03-24 | Proventiv Therapeutics, Llc | Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
| CA2558202A1 (en) * | 2006-09-14 | 2006-11-23 | Reinhold W. Vieth | Vitamin d compositions and method of administration to infants |
| RU2363488C1 (ru) * | 2007-11-26 | 2009-08-10 | Закрытое акционерное общество "Эксесс Байосаинс" | Фармацевтическая композиция на основе пептида, регулирующего нарушения ангиогенеза, и способ ее применения |
| US9259430B2 (en) * | 2008-12-09 | 2016-02-16 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
| RU2410392C2 (ru) * | 2009-02-16 | 2011-01-27 | Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии имени В.В. Закусова РАМН | Дипептидные миметики нейротрофинов ngf и bdnf |
-
2009
- 2009-08-24 EP EP09168522A patent/EP2289555A1/en not_active Ceased
-
2010
- 2010-08-23 PT PT107475261T patent/PT2470214E/pt unknown
- 2010-08-23 MX MX2011011905A patent/MX2011011905A/es active IP Right Grant
- 2010-08-23 US US13/318,650 patent/US10543217B2/en not_active Expired - Fee Related
- 2010-08-23 CN CN201080020393.2A patent/CN102421450B/zh not_active Expired - Fee Related
- 2010-08-23 MY MYPI2011005129A patent/MY162621A/en unknown
- 2010-08-23 BR BRPI1011567-6A patent/BRPI1011567B1/pt not_active IP Right Cessation
- 2010-08-23 EP EP10747526.1A patent/EP2470214B1/en not_active Not-in-force
- 2010-08-23 UA UAA201113554A patent/UA107928C2/ru unknown
- 2010-08-23 KR KR1020117026830A patent/KR20120053987A/ko not_active Application Discontinuation
- 2010-08-23 DK DK10747526.1T patent/DK2470214T3/da active
- 2010-08-23 AU AU2010287043A patent/AU2010287043B2/en not_active Ceased
- 2010-08-23 WO PCT/NL2010/050524 patent/WO2011025368A1/en active Application Filing
- 2010-08-23 PL PL10747526T patent/PL2470214T3/pl unknown
- 2010-08-23 CA CA2759815A patent/CA2759815C/en not_active Expired - Fee Related
- 2010-08-23 JP JP2012526677A patent/JP2013502457A/ja active Pending
- 2010-08-23 NZ NZ596057A patent/NZ596057A/xx not_active IP Right Cessation
- 2010-08-23 ES ES10747526T patent/ES2425095T3/es active Active
- 2010-08-23 SG SG2011084944A patent/SG176135A1/en unknown
- 2010-08-23 RU RU2011146830A patent/RU2635541C2/ru active
-
2011
- 2011-11-02 ZA ZA2011/08056A patent/ZA201108056B/en unknown
- 2011-11-14 CL CL2011002863A patent/CL2011002863A1/es unknown
- 2011-11-17 IL IL216456A patent/IL216456A/en active IP Right Grant
- 2011-11-17 CO CO11156685A patent/CO6460777A2/es not_active Application Discontinuation
-
2015
- 2015-10-15 JP JP2015203528A patent/JP6279529B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2289555A1 (en) | 2011-03-02 |
| CN102421450B (zh) | 2015-09-09 |
| US20120196837A1 (en) | 2012-08-02 |
| KR20120053987A (ko) | 2012-05-29 |
| IL216456A (en) | 2017-04-30 |
| DK2470214T3 (da) | 2013-08-12 |
| ES2425095T3 (es) | 2013-10-11 |
| US10543217B2 (en) | 2020-01-28 |
| PL2470214T3 (pl) | 2013-12-31 |
| MX2011011905A (es) | 2012-01-30 |
| EP2470214B1 (en) | 2013-05-15 |
| CA2759815A1 (en) | 2011-03-03 |
| CL2011002863A1 (es) | 2012-04-13 |
| AU2010287043A1 (en) | 2011-11-10 |
| WO2011025368A1 (en) | 2011-03-03 |
| UA107928C2 (en) | 2015-03-10 |
| CN102421450A (zh) | 2012-04-18 |
| MY162621A (en) | 2017-06-30 |
| AU2010287043B2 (en) | 2014-11-06 |
| NZ596057A (en) | 2013-07-26 |
| IL216456A0 (en) | 2012-01-31 |
| JP2016011313A (ja) | 2016-01-21 |
| BRPI1011567B1 (pt) | 2019-05-14 |
| ZA201108056B (en) | 2012-07-25 |
| EP2470214A1 (en) | 2012-07-04 |
| CA2759815C (en) | 2018-06-12 |
| SG176135A1 (en) | 2011-12-29 |
| JP2013502457A (ja) | 2013-01-24 |
| PT2470214E (pt) | 2013-08-27 |
| BRPI1011567A2 (pt) | 2016-04-05 |
| RU2635541C2 (ru) | 2017-11-13 |
| JP6279529B2 (ja) | 2018-02-14 |
| RU2011146830A (ru) | 2013-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR124500A2 (es) | Aumento de la biodisponibilidad de droga en terapia naltrexona | |
| PH12015502691A1 (en) | Use of high dose pridopidine for treating huntington's disease | |
| MX2011013902A (es) | Tratamiento de esclerosis multiple con laquinimod. | |
| GT201300243A (es) | Derivados de ácido 3-fenilpropiónico ramificados y su uso | |
| BR112015023644A2 (pt) | Dispositivo de inalação, método de controle e programa de computador | |
| CL2008000928A1 (es) | Uso de bacterias probioticas de las especies lactobacillus rhamnosus, cepas atcc 53103 ó cgmcc 13724 para la fabaricacion de un medicamento o formula infantil que permite reducir el riesgo de que el infante desarrolle obesidad a lo largo de su vida. | |
| CL2014001587A1 (es) | Combinacion farmaceutica, composicion farmaceutica o kit farmaceutico que comprenden un inhibidor de dpp-4 y un analogo de glp-1; metodo para tratar y/o prevenir la obesidad o el sobrepesoo para reducir el peso corporal en un paciente humano. | |
| PE20140872A1 (es) | Uso de laquinimod para reducir la fatiga, mejorar el estado funcional y mejorar la calidad de vida en pacientes con esclerosis multiple | |
| UY37318A (es) | Camilla para personas con movilidad reducida | |
| NZ607470A (en) | Disposable skin care device | |
| IL207236A0 (en) | Chair with mechanism to assist standing up and sitting down for elderly or disabled persons | |
| BRPI0702188B8 (pt) | aparelho de aerossol | |
| AR111374A1 (es) | Uso de lik066 en pacientes con insuficiencia cardíaca | |
| ES2580979R1 (es) | Silla de ruedas eléctrica | |
| CO6460777A2 (es) | Método para el tratamiento de la fragiliad | |
| NO20055884L (no) | Asenanin for behandling av schizofreni hos en pasient med overvekt eller predisposisjon for overvekt | |
| AR048460A1 (es) | Tratamiento de la funcion respiratoria alterada con gaboxadol | |
| Khan et al. | Disability management and rehabilitation for persons with multiple sclerosis | |
| KR20150003309U (ko) | 자외선 램프를 이용한 에스컬레이터 손잡이 벨트 소독장치 | |
| Paul | Pericarditis, pericardial effusion and para-cardiac pleural effusion: case report | |
| TH146677A (th) | องค์ประกอบทางเภสัชกรรมซึ่งประกอบรวมด้วยแอนาบอลิค สเตอรอยด์ และสารประกอบวิตามิน d สำหรับใช้ในการผลิตยาเพื่อบำบัดความอ่อนแอ | |
| CR20150624U (es) | Cama médica con sistema de evacuación electromecánica de desechos orgánicos | |
| Abbott’s ARCHITECT | Patient deterioration | |
| RU2018110031A (ru) | Способ лечения и профилактика гриппа | |
| Ameen | Stevens-Johnson/toxic epidermal necrolysis overlap syndrome: case report |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |